Lead Plaintiff Deadline Approaching: Infinity Pharmaceuticals, Inc. Investors Should Contact Robbins LLP for Information About the Infinity Pharmaceuticals, Inc. Class Action Infinity Pharmaceuticals, Inc. (INFI) Misled Investors Regarding its Business Prospects

INFI Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Infinity Pharmaceuticals, Inc. SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Infinity...